ARCHIVES

As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Interim Dean Henney Looking for Cancer Center Director; Shingleton Gets James Ewing Award

June 10, 1988

Judge Sentences Former BMS Exec Bodner To Write Book Reflecting On His Experience

June 12, 2009

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

In Brief: Hawaii Study finds No Increase Risk for Large Bowell Cancer From High Intake Of Saturated Fat

October 12, 1984

Blumenthal Says Action Plan To Issue “New Priority Areas”

October 24, 1996

Komen Officials Say Charity is Stabilizing Despite 22 Percent Drop in Contributions

January 24, 2014